Rentschler exits cell and gene business due to low demand, will prioritize biologics

German CDMO Rentschler Biopharma is closing down its cell and gene therapy operations and shuttering a facility in the UK, which could affect up to 30 employees, a company spokesperson told Endpoints News in an ...